Narendra Modi's Washington test

Narendra Modi's Washington test

If Modi gets the world’s biggest power right, his pursuit of larger global goals...
Small banks or banks for ‘small’ people?

Small banks or banks for ‘small’ people?

Unless appropriate sub-limits are imposed on loans, there is a serious...

Piramal Group's private equity to raise $185 mn in new fund

Dec 07 2012, 11:00 IST
Comments 0
IndiaVenture Advisors, a private equity fund owned by Indian drugmaker Piramal Enterprises , is planning to raise up to 10 billion rupees ($185 million) for a new fund that will invest in healthcare and education, its chairman said. (Reuters) IndiaVenture Advisors, a private equity fund owned by Indian drugmaker Piramal Enterprises , is planning to raise up to 10 billion rupees ($185 million) for a new fund that will invest in healthcare and education, its chairman said. (Reuters)
SummaryInvestors have stepped up ploughing money into the healthcare sector in India.

IndiaVenture Advisors, a private equity fund owned by Indian drugmaker Piramal Enterprises , is planning to raise up to 10 billion rupees ($185 million) for a new fund that will invest in healthcare and education, its chairman said.

Investors have stepped up ploughing money into the healthcare sector in India, home to more than 1.2 billion people, betting on steadier returns than in other businesses that have been hit by an economic slowdown. "It's a defensive sector and is recession-proof," IndiaVenture Chairman A.K. Purwar said. "On top of that, we have our parent group's strength to leverage and do better value addition."

IndiaVenture currently manages about 3.7 billion rupees. Private equity investments in Indian healthcare have nearly quadrupled to $520.36 million so far this year from $137.41 million in the same period a year ago.

In comparison, private equity investments across all sectors in India have fallen 17.5 percent to $3.26 billion from $3.95 billion during the same period last year, the data showed.

"We are about to start formal marketing of the fund," said Purwar, a former chairman of top lender State Bank of India .

The bulk of the fund would be raised from India, while global investors would be tapped for about 20 percent, he said. Piramal Enterprises, controlled by billionaire Ajay Piramal, is one of India's leading healthcare firms. It sold its India formulations business to U.S.-based Abbott Laboratories for $3.7 billion in 2010.

Ads by Google

More from Latest News - Industry

Reader´s Comments
| Post a Comment
Please Wait while comments are loading...